Tonix Pharmaceuticals releases more data from second positive Phase 3 clinical trial of TNX-102 SL

Tonix Pharmaceuticals releases more data from second positive Phase 3 clinical trial of TNX-102 SL

Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SLПодробнее

Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

Tonix Pharmaceuticals Presents Promising Data on Fibromyalgia Treatment at Global ConferenceПодробнее

Tonix Pharmaceuticals Presents Promising Data on Fibromyalgia Treatment at Global Conference

Tonix Pharmaceuticals CEO Discusses New Drug Application for Fibromyalgia TreatmentПодробнее

Tonix Pharmaceuticals CEO Discusses New Drug Application for Fibromyalgia Treatment

Tonix Pharmaceuticals fibromyalgia study published in American College of RheumatologyПодробнее

Tonix Pharmaceuticals fibromyalgia study published in American College of Rheumatology

Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of FibromyalgiaПодробнее

Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of Fibromyalgia

Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SLПодробнее

Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SL

Tonix Pharmaceuticals (TNXP) releases TNX-102 SL for the Treatment of PTSDПодробнее

Tonix Pharmaceuticals (TNXP) releases TNX-102 SL for the Treatment of PTSD

Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trialПодробнее

Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial

Tonix Pharmaceuticals updates on fibromyalgia study enrollment, FY 2020 resultsПодробнее

Tonix Pharmaceuticals updates on fibromyalgia study enrollment, FY 2020 results

Tonix Pharmaceuticals (TNXP) NobleCon18 Presentation ReplayПодробнее

Tonix Pharmaceuticals (TNXP) NobleCon18 Presentation Replay

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)Подробнее

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Tonix Pharmaceuticals gets FDA Fast Track designation for fibromyalgia therapyПодробнее

Tonix Pharmaceuticals gets FDA Fast Track designation for fibromyalgia therapy

Could TNXP Reach 3-4$ soon?! - Reddit recommendsПодробнее

Could TNXP Reach 3-4$ soon?! - Reddit recommends

Overview of the Phase III ENHANCE trial schemaПодробнее

Overview of the Phase III ENHANCE trial schema

$TNXP Stock - Upcoming milestones + Reverse split risk! - Due Diligence & Technical analysisПодробнее

$TNXP Stock - Upcoming milestones + Reverse split risk! - Due Diligence & Technical analysis

$TNXP TONIX Pharmaceuticals FDA APPROVAL FOR INCURABLE DISEASEПодробнее

$TNXP TONIX Pharmaceuticals FDA APPROVAL FOR INCURABLE DISEASE

Tonix Pharmaceuticals (TNXP Stock) is Still Ready to Take Off and With Other Great Ideas as Well!Подробнее

Tonix Pharmaceuticals (TNXP Stock) is Still Ready to Take Off and With Other Great Ideas as Well!